This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Algenics, L'institut Francais De Recherche Pour L'exploitation De La Mer (Ifremer), Université´de Rouen. Active years: 2017.
Company Filing History:
1 out of 1 
1 out of 1 
1 out of 33 
Years Active: 2017
Title: Romain Louvet: Innovator in Glycosylation Technology
Introduction
Romain Louvet is a notable inventor based in Evreux, France. He has made significant contributions to the field of biotechnology, particularly in the area of glycosylation processes. His innovative work has led to the development of a unique patent that enhances the production of glycosylated polypeptides.
Latest Patents
Romain Louvet holds a patent that involves a transformed organism containing a nucleic acid sequence operatively linked to a promoter. This sequence encodes an N-acetylglucosaminyltransferase I and/or an α-Mannosidase II. Notably, at least one β-N-acetylglucosaminidase of the transformed organism has been inactivated. The patent describes a method for producing a glycosylated polypeptide, which includes culturing the transformed organism and purifying the expressed and glycosylated polypeptide.
Career Highlights
Throughout his career, Romain Louvet has worked with esteemed institutions such as Université de Rouen and L'Institut Français de Recherche pour l'Exploitation de la Mer (Ifremer). His work in these organizations has allowed him to collaborate with other experts in the field and contribute to groundbreaking research.
Collaborations
Romain has collaborated with notable colleagues, including Muriel Bardor and Bruno Saint-Jean. These partnerships have enriched his research and expanded the impact of his innovations in glycosylation technology.
Conclusion
Romain Louvet's contributions to biotechnology, particularly through his patent on glycosylated polypeptides, highlight his role as an influential inventor. His work continues to pave the way for advancements in the field.